October 10, 2019

CMS Proposes Hospital 340B Price Survey to Determine 340B Acquisition Costs

On September 30,CMS published a notice of proposed collection of information from 340B Program participating hospitals to obtain "acquisition costs for specified covered outpatient drugs." CMS stated the purpose behind this data collection is to "ensure that the Medicare program pays for specified covered outpatient drugs purchased under the 340B program at amounts that approximate what hospitals actually pay to acquire the drugs." Essentially, this move signals the continued desire of CMS to set reimbursement rates for drugs under the 340B Program at amounts approximating the entity's 340B Program acquisition cost. The comment period for the proposed collection of information closes on November 29, 2019.